Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

LYEL holding history

Lyell Immunopharma, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings

Shares (Q2 2026)
18,695
Value
$262.7K
% of portfolio
<0.1%
Quarters held
19
Since Q2 2021
Holdings of LYEL by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,695$262.7K<0.1%−362,767−95.1%ReducedHolders
Q1 2026381,462$7.65M<0.1%+56,761+17.5%AddedHolders
Q4 2025324,701$9.99M<0.1%−14,790−4.4%ReducedHolders
Q3 2025339,491$5.51M<0.1%+68,208+25.1%AddedHolders
Q2 2025271,283$2.40M<0.1%+45,940+20.4%AddedConverted for a 1-for-20 splitHolders
Q1 20254,506,857$2.35M<0.1%+752,112+20.0%AddedHolders
Q4 20243,754,745$2.32M<0.1%+3,752,968+211,196.8%AddedHolders
Q3 20241,777$2.45K<0.1%−273,944−99.4%ReducedHolders
Q2 2024275,721$399.8K<0.1%−510,623−64.9%ReducedHolders
Q1 2024786,344$1.75M<0.1%−2,690,884−77.4%ReducedHolders
Q4 20233,477,228$6.75M<0.1%+2,730,085+365.4%AddedHolders
Q3 2023747,143$1.10M<0.1%+706,419+1,734.7%AddedHolders
Q2 202340,724$129.5K<0.1%−18,498−31.2%ReducedHolders
Q1 202359,222$139.8K<0.1%+42,148+246.9%AddedHolders
Q4 202217,074$59.2K<0.1%+17,074NewHolders
Q2 20220$00.0%−249,038−100.0%Sold outHolders
Q1 2022249,038$1.26M<0.1%−93,656−27.3%ReducedHolders
Q4 2021342,694$2.65M<0.1%+154,965+82.5%AddedHolders
Q3 2021187,729$2.78M<0.1%−140,304−42.8%ReducedHolders
Q2 2021328,033$5.33M<0.1%+328,033NewHolders